Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Whey protein + creatine is a synergistic dietary supplement combination widely utilized in sports nutrition and clinical settings to enhance muscle mass, strength, and physical performance. Whey protein, a high-quality dairy-derived protein rich in branched-chain amino acids (BCAAs)—particularly leucine—serves as a potent stimulator of muscle protein synthesis (MPS) via the activation of the mechanistic target of rapamycin complex 1 (mTORC1) pathway. Creatine, typically administered as creatine monohydrate, increases intramuscular phosphocreatine stores, facilitating the rapid regeneration of adenosine triphosphate (ATP) during high-intensity anaerobic activity. Together, the combination addresses both the structural requirements for muscle remodeling and the energetic demands of resistance training. Beyond athletic performance, this combination is investigated for its therapeutic potential in mitigating muscle wasting associated with sarcopenia, aging, and chronic diseases such as cancer-related cachexia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on whey protein + creatine.